Buruli ulcer
Human Vaccines · 2011-11 · 7 (11) · 1198-1203
DOI: 10.4161/hv.7.11.17751 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Vaccines, online erschienen am 27.10.2014. Verfasst von Thorbjorg Einarsdottir und 1 weiteren Autor:innen. Beteiligte Einrichtung: WIV-ISP Site Ukkel, Service Immunology, Brussels, Belgium. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Buruli Ulcer (BU) is a neglected, necrotizing skin disease, caused by M. ulcerans, that can leave patients with prominent scars and lifelong disability. M. ulcerans produces a diffusible lipid toxin, mycolactone, essential for bacterial virulence. Prevention is difficult as little is known about disease transmission and there is no vaccine. There have been several recent advances in the field. These include sequencing of the bacterial genome and of the giant plasmid responsible for mycolactone synthesis, better understanding of the bacterial lifecycle and of the mechanism of action of the toxin. This work has revealed a number of possible vaccine candidates, some of which are shared with other mycobacteria, e.g. M. tuberculosis, while other targets are unique to M. ulcerans. In this review, we discuss several M. ulcerans vaccine targets and vaccination methods, and outline some of the gaps in our understanding of the bacterium and the immune response against it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- WIV-ISP Site Ukkel, Service Immunology, Brussels, Belgium.
Zitieren
APA
Einarsdottir, T., & Huygen, K. (2011). Buruli ulcer. Human Vaccines, 7(11), 1198-1203. https://doi.org/10.4161/hv.7.11.17751
Vancouver
Einarsdottir T, Huygen K. Buruli ulcer. Human Vaccines. 2011;7(11):1198-1203. doi:10.4161/hv.7.11.17751
BibTeX
@article{Einarsdottir2011,
author = {Einarsdottir, Thorbjorg and Huygen, Kris},
title = {Buruli ulcer},
journal = {Human Vaccines},
year = {2011},
volume = {7},
number = {11},
pages = {1198--1203},
doi = {10.4161/hv.7.11.17751}
}
EUVIMED